Suchergebnisse - "Montoya, Skye"

PubPharm (12)

1

Combination Venetoclax and Selinexor Effective in Relapsed Refractory Multiple Myeloma with Translocation t(11;14)

enthalten in: bioRxiv.org | 2024

von Nguyen, N. | Chaudhry, S. | Totiger, T. | +16

2

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

enthalten in: Science (New York, N.Y.) | 2024

von Montoya, S. | Bourcier, J. | Noviski, M. | +50

CommentIn: Nat Rev Drug Discov. 2024 Mar;23(3):173. - PMID 38336888

3

Resisting the Resistance : Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)

enthalten in: Genes | 2023

von Chirino, A. | Montoya, S. | Safronenka, A. | +1

4

Non-Covalent Bruton's Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia

enthalten in: Cancers | 2023

von Montoya, S. | Thompson, M.

5

Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms

enthalten in: Leukemia research | 2023

von Jahn, J. | Diamond, B. | Hsu, J. | +5

6

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies

enthalten in: Journal of cellular and molecular medicine | 2023

von Totiger, T. | Chaudhry, S. | Musi, E. | +7

7

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies

enthalten in: Journal of Cellular and Molecular Medicine | 2023

von Totiger, T. | Chaudhry, S. | Musi, E. | +7

8

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy

enthalten in: Blood | 2022

von Handa, S. | Lee, J. | Derkach, A. | +12

CommentIn: Blood. 2022 Dec 22;140(25):2649-2650. - PMID 36548021

9

Protein biomarkers for response to XPO1 inhibition in hematologic malignancies

enthalten in: bioRxiv.org | 2022

von Totiger, T. | Chaudhry, S. | Musi, E. | +7

10

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)

enthalten in: NPJ precision oncology | 2022

von Nguyen, N. | Chaudhry, S. | Totiger, T. | +16